Shares of Select Medical Holdings Co. (NYSE:SEM – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $26.80.
Several equities research analysts recently weighed in on SEM shares. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Monday, February 24th. Mizuho assumed coverage on Select Medical in a research report on Wednesday, April 16th. They set an “outperform” rating and a $25.00 price objective for the company. UBS Group lowered their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. Finally, Royal Bank of Canada cut their target price on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday, February 24th.
Check Out Our Latest Research Report on SEM
Institutional Inflows and Outflows
Select Medical Price Performance
Shares of SEM opened at $16.35 on Wednesday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of 9.91, a PEG ratio of 0.64 and a beta of 1.38. Select Medical has a 52 week low of $14.99 and a 52 week high of $40.98. The stock has a 50 day moving average of $17.27 and a 200-day moving average of $22.83.
Select Medical (NYSE:SEM – Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, analysts forecast that Select Medical will post 1.17 EPS for the current year.
Select Medical Cuts Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend was Monday, March 3rd. Select Medical’s dividend payout ratio is currently 15.15%.
About Select Medical
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
See Also
- Five stocks we like better than Select Medical
- P/E Ratio Calculation: How to Assess Stocks
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- Why is the Ex-Dividend Date Significant to Investors?
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.